Rob Dillard

DocwireNews

The findings of a new study suggest that hypoxia inducible factor-1 alpha (HIF-1&alpha;) may be a surrogate marker after revascularization in patients with peripheral arterial disease (<a href="https://www.docwirenews.com/pad-knowledge-hub/pad-knowledge-hub-picks/fda-approves-rivaroxaban-plus-aspirin-for-lower-extremity/">PAD</a>). The results appeared in the journal Vascular Specialist International.HIF)-1 is a dimeric protein complex that plays an chief role in the body&rsquo;s response to hypoxia. &ldquo;The relationship between peripheral arterial disease (PAD) and HIF-1 has been previously reported,&rdquo; the researchers wrote. &ldquo;However, to the best of our knowledge, no study has compared the preoperative and postoperative HIF-1 levels after open and/or endovascular revascularization in patients with advanced PAD. In this prospective observational study, we aimed to investigate the value of HIF-1 in the prognosis of patients with PAD who underwent an open or endovascular intervention.&rdquo;In this prospective study, researchers assessed 40 patients with PAD (mean age, 62). Open surgery was performed in 16 patients, and endovascular intervention was performed in 34 patients. At preoperative (T1), postoperative day 1 (T2), and month 3 (T3), the serum HIF-1&alpha; levels were checked using the ELISA technique, the researchers noted.According to the results of the study, at month three, the ankle-brachial index was discernibly higher than the preoperative value (P&lt;0.001). Serum HIF-1&alpha; levels at T1, T2, and T3 were 2.0&plusmn;1.7 ng/mL, 1.9&plusmn;1.7 ng/mL, and 1.6&plusmn;1.4 ng/mL, respectively, the researchers noted. They observed that Serum HIF-1&alpha; levels between T1 and T3 and between T2 and T3 were significantly different (P&lt;0.05).One of the biggest limitations of study was the small sample size, which was attributed to financial reasons. HIF-1&alpha; measurement in the healthy control group was not performed, according to the researchers. They wrote that, therefore, &ldquo;data on the normal HIF-1&alpha; level, the cutoff value of significant ischemic lesion, sensitivity, or specificity were not available.&rdquo;&ldquo;The HIF-1&alpha; levels were decreased in all patients on postoperative days, T2 and T3, compared with the preoperative values. Our results indicated that HIF-1&alpha; may be a surrogate marker after revascularization in patients with PAD. Further studies are needed to analyze the sensitivity, specificity, and cut-off values of HIF-1&alpha; in patients with PAD,&rdquo; the researchers concluded.

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

HER2 Breast Cancer

Trodelvy Plus Keytruda Significantly Improves Progression-Free Survival in PD-L1+ mTNBC, Phase III Data Show

Triple-Negative Breast Cancer

Jordana Jampel

Actress Michelle Trachtenberg's Premature Death From Diabetes Reveals Dangers of Chronic Complications

Diabetes

Latest News

Hypoxia Inducible Factor-1 Alpha as a Surrogate Marker in PAD

Atherosclerotic Disease

The findings of a new study suggest that hypoxia inducible factor-1 alpha (HIF-1α) may be a surrogate marker after revascularization in patients with peripheral arterial ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe